Roper Technologies, Inc. (ROP) Stock Price & How to Invest

Roper Technologies has spent the past decade reinventing itself from an industrial tools and equipment maker into a diversified holding company whose center of gravity is vertical-market software. It operates through three segments: Application Software (businesses like Deltek for government contractors, Vertafore in insurance, Aderant for law firms, Frontline in K-12 education, and Clinisys in diagnostics), Network Software (network-effect platforms such as DAT in freight and iPipeline in insurance), and Technology Enabled Products (Neptune water meters, Verathon and CIVCO in medical devices). More than half of total revenue is now recurring, coming from SaaS subscriptions, maintenance and transaction fees, and application plus network software together generate roughly three-quarters of revenue.

The investment picture is that of a capital-allocation compounder. Roper acquires high-margin, cash-generative software leaders in small niches, largely leaves them decentralized, and redeploys the resulting free cash flow into the next deal, with over $6 billion of capacity for M&A and buybacks. Q1 2026 revenue rose about 11% to roughly $2.10 billion on 6% organic growth, and the company lifted full-year adjusted earnings guidance. The trade-off is valuation and balance-sheet dependence: ROP trades at a premium multiple, carries meaningful debt and goodwill from its deal machine, and its returns hinge on continuing to buy good businesses at sensible prices.

The clearest risk is valuation: ROP trades at a premium multiple, so disappointing results or a slower deal pace can compress the stock even if the business stays healthy. The model depends on continually acquiring good companies at sensible prices, and rising multiples for premium software assets can weigh on returns over time. Aggressive M&A has also lifted leverage (around 3.1x) and left goodwill and intangibles as a large share of the balance sheet, creating impairment risk if acquired businesses underperform. AI could disrupt the switching costs and stickiness that protect its software niches. Finally, as a decentralized holding company spanning dozens of businesses, execution and integration risk is spread across many units and is harder for outsiders to monitor.

15 analysts publish price targets on ROP, averaging $440.25 against a $391.97 price as of August 2026, or +12.3%. The published targets run from $335.00 to $550.00, a moderate spread, and the ratings split 7 buy, 11 hold, 2 sell. Over the last six months there have been 5 raises and 3 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full ROP forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Roper Technologies, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Acquisition-driven compounding. Roper's core engine is buying niche vertical-software and technology businesses and redeploying their cash into new deals. The most optimistic published target, $550.00, assumes this works close to its best case.

The case against. The clearest risk is valuation: ROP trades at a premium multiple, so disappointing results or a slower deal pace can compress the stock even if the business stays healthy. The most pessimistic target, $335.00, is roughly what ROP is worth if this bites instead.

Read the full bull and bear case on ROP, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Roper Technologies, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$8.0 billion
• Q1 2026 revenue: ~$2.10 billion (up ~11% YoY)
• Market cap: ~$35-36 billion
• FY2026 adjusted DEPS guidance: ~$21.80-$22.05
• P/E ratio: ~23x trailing, ~16-18x forward
• Dividend yield: ~1% (annual dividend ~$3.64)

Roper's Q1 2026 revenue rose about 11% year over year to roughly $2.10 billion, split between 6% organic growth and 5% from acquisitions, and it raised full-year adjusted earnings guidance while adding to its buyback authorization. Net margins sit near 19% to 20% and adjusted EBITDA margins around 38%, reflecting the software-heavy mix. The forward multiple in the mid-to-high teens is well below the stock's longer-run median, which bulls read as more reasonable and bears view as still-full for a business dependent on ongoing M&A.

If you want ROP exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

These are the investment theses ROP naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to ROP: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get ROP exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (IEFA, EFA, FIW), which spreads the position across many companies. Or build it into a focused thematic portfolio, so ROP sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where ROP fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

ROP is a high-quality software compounder built on acquisitions and recurring revenue, priced accordingly, so the debate is about paying a premium for consistency versus M&A execution and valuation risk.

Whether ROP is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ROP a buy or a sell?, and where the stock could go from here in the ROP stock forecast.

For income investors, whether ROP pays a dividend and how the payout looks is covered in does ROP pay a dividend? And to weigh ROP against a peer, read the full side-by-side comparisons: ROP vs AWK and ROP vs WTRG.